TFEB and familial hypercholesterolemia: By using hepatic TFEB knockdown approach, we further show that preventing hepatic TFEB activation abolishes the beneficial effects of GSK against diet-induced hypercholesterolemia, suggesting that hepatic TFEB activation is indeed required for GSK-mediated overall cholesterol homeostasis in response to high dietary cholesterol challenge.